In this study, immunohistochemistry and western blot assays demonstrated that CLDN6 was significantly upregulated in ovarian cancer tissues and a variety of ovarian cancer cell lines and localized in cell membranes. This evidence concerns the gene CLDN6 and ovarian carcinoma.